Mobilization of endothelial precursor cells: Systemic vascular response to musculoskeletal trauma

Journal of Orthopaedic Research

Volumn 25, Issue 1, 2007, Pages 44-50

  Laing, Alan J ^a   Dillon, J P ^a   Condon, E T ^a   Street, J T ^a   Wang, J H ^a   McGuinness, A J ^a   Redmond, H P ^a  

^a University College Cork and INFANT Centre   (Ireland)

Author keywords

Endothelial precursor cells; Neovascularization; Vasculogenesis

Indexed keywords

1,1' DIOCTADECYL 3,3,3',3' TETRAMETHYLINDOCARBOCYANINE; ACETYL LOW DENSITY LIPOPROTEIN; CD133 ANTIGEN; CD34 ANTIGEN;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD ANALYSIS; BLOOD VESSEL REACTIVITY; CELL DIFFERENTIATION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FRACTURE HEALING; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; LEUKOCYTE CULTURE; MALE; MONONUCLEAR CELL; MUSCULOSKELETAL INJURY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TIBIA SHAFT FRACTURE; VASCULAR ENDOTHELIUM;

ADULT; ANTIGENS, CD34; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS; TIBIAL FRACTURES;

EID: 33846035640     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20228     Document Type: Article

References (40)

1. Folkman J. 1974. Tumor angiogenesis. Adv Cancer Res 19:331-358.
2. Folkman J. 1985. Tumor angiogenesis. Adv Cancer Res 43:175-203.
3. Geiger F, Bertram H, Berger I, et al. 2005. Vascular endothelial growth factor gene-activated matrix (VEGF(165)-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res 20:2028-2035.
4. Tarkka T, Sipola A, Jamsa T, et al. 2003. Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues. J Gene Med 5:560-566.
5. Street J, Winter D, Wang JH, et al. 2000. Is human fracture haematoma inherently angiogenic? Clin Orthop 378:224-237.
6. Eckardt H, Ding M, Lind M, et al. 2005. Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model. J Bone Joint Surg Br 87:1434-1438.
7. Beam HA, Parsons JR, Lin SS. 2002. The effects of blood glucose control upon fracture healing in the BB Wistar rat with diabetes mellitus. J Orthop Res 20:1210-1216.
8. Macey LR, Kana SM, Jingushi S, et al. 1989. Defects of early fracture-healing in experimental diabetes. J Bone Joint Surg Am 71:722-733.
9. Lorenzi M, Nordberg JA, Toledo S. 1987. High glucose prolongs cell-cycle traversal of cultured human endothelial cells. Diabetes 36:1261-1267.
10. Salameh A, Zinn M, Dhein S. 1997. High D-glucose induces alterations of endothelial cell structure in a cell-culture model. J Cardiovasc Pharmacol 30:182-190.
11. Tirziu D, Moodie KL, Zhuang ZW, et al. 2005. Delayed arteriogenesis in hypercholesterolemic mice. Circulation 112:2501-2509.
12. Chen F, Osterman AL, Mahony K. 2001. Smoking and bony union after ulna-shortening osteotomy. Am J Orthop 30:486-489.
13. Daftari TK, Whitesides TE Jr, Heller JG, et al. 1994. Nicotine on the revascularization of bone graft. An experimental study in rabbits. Spine 19:904-911.
14. Lu C, Miclau T, Hu D, et al. 2005. Cellular basis for agerelated changes in fracture repair. J Orthop Res 23:1300-1307.
15. Sadoun E, Reed MJ. 2003. Impaired angiogenesis in aging is associated with alterations in vessel density, matrix composition, inflammatory response, and growth factor expression. J Histochem Cytochem 51:1119-1130.
16. Asahara T, Murohara T, Sullivan A, et al. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967.
17. Asahara T, Takahashi T, Masuda H, et al. 1999. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18:3964-3972.
18. Asahara T, Masuda H, Takahashi T, et al. 1999. Bone marrow origin of endothelial progenitor cells responsible for post natal vasculogenesis in physiological and pathological neoascularisation. Circ Res 85:221-228.
19. Shi Q, Rafii S, Wu MD, et al. 1998. Evidence for circulating bone marrow-derived endothelial cells. Blood 92:362-367.
20. Healy L, May G, Gale K, et al. 1995. The stem cell antigen CD34 functions as a regulator of hemopoietic cell adhesion. Proc Natl Acad Sci USA 92:12240-12244.
21. Schatteman GC, Hanlon HD, Jiao C, et al. 2000. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 106:571-578.
22. Murohara T, Ikeda H, Duan J, et al. 2000. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 105:1527-1536.
23. Morii T, Nishikawa K, Shimoyama T, et al. 1994. Quantitative flow-cytometric analysis of CD34-positive stem cells in peripheral blood stem cell harvests. Jpn J Clin Hematol 35:649-656.
24. Peichev M, Naiyer AJ, Pereira D, et al. 2000. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 95:952-958.
25. Reyes M, Lund T, Lenvik T, et al. 2001. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98:2615-2625.
26. Gehling UM, Ergun S, Schumacher U, et al. 2000. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95:3106-3111.
27. Kaushal S, Amiel GE, Guleserian KJ, et al. 2001. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 7: 1035-1040.
28. Murayama T, Tepper OM, Silver M, et al. 2002. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol 30:967-972.
29. Gill M, Dias S, Hattori K, et al. 2001. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 88:167-174.
30. Shintani S, Murohara T, Ikeda H, et al. 2001. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103:2776-2779.
31. Ferrara N, Carver-Moore K, Chen H. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442.
32. Iwaguro H, Yamaguchi J, Kalka C, et al. 2002. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105:732-738.
33. Shalaby F, Rossant J, Yamaguchi T, et al. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66.
34. Takahashi T, Kalka C, Matsuda H, et al. 1999. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5:434-438.
35. Kalka C, Masuda H, Takahashi T, et al. 2000. Transplantation of ex-vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97:3422-3427.
36. Kamihata H, Matsubara H, Nishiue T, et al. 2001. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104:1046-1052.
37. Kocher AA, Schuster MD, Szabolcs MJ, et al. 2001. Neovascularisation of ischemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7:430-436.
38. Lin Y, Weisdorf DJ, Solovey A, et al. 2000. Origins of circulating endothelial cells and endothelial outgrowth from. J Clin Invest 105:71-77.
39. Street J, Bao M, deGuzman L, et al. 2002. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99:9656-9661.
40. Yin AH, Miraglia S, Zanjani ED, et al. 1997. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90:5002-5012.